Article
Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity.
PLoS neglected tropical diseases - 1 Jun 2022
Park Ji-Hoon, Kim Min-Hee, Sutanto Edwin, Na Seok-Won, Kim Min-Jae, Yeom Joon Sup, Nyunt Myat Htut, Abbas Elfaki Mohammed Mohieldien, Abdel Hamid Muzamil Mahdi, Cha Seok Ho, Alemu Sisay Getachew, Sriprawat Kanlaya, Anstey Nicholas M, Grigg Matthew J, Barber Bridget E, William Timothy, Gao Qi, Liu Yaobao, Pearson Richard D, Price Ric N, Nosten Francois, Yoon Sung-Il, No Joo Hwan, Han Eun-Taek, Auburn Sarah, Russell Bruce, Han Jin-Hee
Abstract excerpt
Plasmodium vivax is the most widespread cause of human malaria. Recent reports of drug resistant vivax malaria and the challenge of eradicating the dormant liver forms increase the importance of vaccine development against this relapsing disease. P. vivax reticulocyte binding protein 1a (PvRBP1a) is a potential vaccine candidate, which is involved in red cell tropism, a crucial step in the merozoite invasion of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
